Welcome to our dedicated page for Blum Holdings SEC filings (Ticker: BLMH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Cannabis disclosures can be a maze—especially when one company operates cultivation sites, retail dispensaries and multiple licensed subsidiaries. Blum Holdings (BLMH) packs all of that detail, plus tax code 280E nuances, into hundreds of SEC pages. If finding cash flow from flower sales or updates on state licenses feels overwhelming, you are not alone.
Stock Titan’s AI reads every line so you do not have to. Need Blum Holdings insider trading Form 4 transactions or alerts on Blum Holdings Form 4 insider transactions real-time? They land instantly in your dashboard. Wonder what changed in the latest Blum Holdings quarterly earnings report 10-Q filing or want a Blum Holdings annual report 10-K simplified? Our AI summary highlights segment revenue, cultivation yield data and risk-factor shifts. It also ties each Blum Holdings 8-K material events explained to potential market impact, from new dispensary openings to legal settlements.
Use the platform to:
- Compare retail vs. wholesale margins with one-click Blum Holdings earnings report filing analysis
- Track executive incentives through the Blum Holdings proxy statement executive compensation section
- Spot patterns in Blum Holdings executive stock transactions Form 4 before they hit headlines
Blüm Holdings, Inc. executed two unsecured promissory notes on September 16 and 17, 2025 for $500,000 and $250,000 respectively, creating $750,000 of principal indebtedness due in 2027. Each note bears an 8.0% annual interest rate payable monthly in arrears beginning January 15, 2026, and may be prepaid without penalty. At the lender's election each note is convertible into a convertible promissory note that will automatically convert into Blüm common stock at a conversion price equal to 85% of a $20,900,000 pre-money valuation (implying $0.98 per share on a fully diluted basis). The company also issued warrants: up to 571,429 shares exercisable at $0.35 per share for the $500,000 note and up to 285,714 shares at $0.35 per share for the $250,000 note. The $500,000 note formalizes funds advanced on August 11, 2025. Full terms are filed as Exhibits 10.1 and 10.2.
Blüm Holdings filed Amendment No. 1 to its Form 8-K to correct its prior disclosure about a previously announced management services transaction with a licensed Northern California cannabis retail operator. The amendment states that Blüm originally reported it would file financial statements and pro forma financial information for the target within 71 days, but after further analysis concluded those filings are not required because the Transaction is not "significant" under Regulation S-X. The amendment therefore removes references to any subsequent filing of financial statements or pro forma information; no financial statements or pro forma information are provided.
FAQ
What is the current stock price of Blum Holdings (BLMH)?
What is the market cap of Blum Holdings (BLMH)?
